A Phase 1, Randomized, Placebo-And Positive-Controlled Crossover Study To Determine The Effect Of A Single-Dose Of PH-797804 On QTc Interval In Healthy Volunteers
Phase of Trial: Phase I
Latest Information Update: 14 Aug 2013
Price : $35 *
At a glance
- Drugs PH 797804 (Primary) ; Moxifloxacin
- Indications Chronic obstructive pulmonary disease
- Focus Pharmacodynamics
- 14 Aug 2013 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 08 Aug 2013 Planned End Date changed from 1 Jul 2013 to 1 Aug 2013 as reported by ClinicalTrials.gov.
- 08 Jul 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.